Shopping Cart 0
Cart Subtotal
USD 0

Inhalation Sciences Sweden AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Summary

Inhalation Sciences Sweden AB (ISAB) develops and sells innovative laboratory equipment for inhalation research and provides drug development services. The company's product portfolio includes PreciseInhale and LaminarPace systems. It sells tools and services which accelerates the drug discovery timelines to reduce attrition rates in the clinical phase. ISAB's PreciseInhale, is an advanced laboratory technology system for inhalation drug development in therapeutic areas of asthma and COPD (chronic obstructive pulmonary disease), migraine, impotence, diabetes and influenza. Its PreciseInhale platform is used for screening and preclinical evaluation of candidate drugs and new drug formulations intended for inhalation. The company offers data for pharmacokinetic studies to labs, pharma and research companies. ISAB is headquartered in Huddinge, Sweden.

Inhalation Sciences Sweden AB-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Inhalation Sciences Sweden AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Inhalation Sciences Sweden AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Inhalation Sciences Sweden AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Inhalation Sciences Sweden AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Inhalation Sciences Sweden AB, Medical Devices Deals, 2012 to YTD 2018 9

Inhalation Sciences Sweden AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Inhalation Sciences Sweden AB, Pharmaceuticals & Healthcare, Deal Details 11

Venture Financing 11

Inhalation Sciences Raises Funds through Venture Financing 11

Equity Offering 12

Inhalation Sciences Raises USD0.4 million in Private Placement of Shares 12

Acquisition 13

KDev Investments Sells Stake in Inhalation Sciences 13

BrainsToVentures And Rosetta Capital Acquire Minority Stake In 13 Portfolio Companies Of Karolinska Development For USD 34 Million 14

Inhalation Sciences Sweden AB-Key Competitors 17

Inhalation Sciences Sweden AB-Key Employees 18

Inhalation Sciences Sweden AB-Locations And Subsidiaries 19

Head Office 19

Recent Developments 20

Financial Announcements 20

Aug 22, 2018: Inhalation Sciences publishes interim report for the second quarter of 2018 20

Corporate Communications 22

Apr 19, 2018: Inhalation Sciences Names Lena Heffler As CEO 22

Government and Public Interest 23

Oct 26, 2017: AstraZeneca report finds PreciseInhale 'reduces the risk' of failure when developing inhaled drugs 23

Other Significant Developments 24

May 08, 2018: Inhalation Sciences' new CEO Lena Heffler: science, sales, win-win 24

Appendix 25

Methodology 25

About GlobalData 25

Contact Us 25

Disclaimer 25


List Of Figure

List of Figures

Inhalation Sciences Sweden AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Inhalation Sciences Sweden AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Inhalation Sciences Sweden AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Inhalation Sciences Sweden AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Inhalation Sciences Sweden AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Inhalation Sciences Sweden AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Inhalation Sciences Sweden AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Inhalation Sciences Sweden AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Inhalation Sciences Sweden AB, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Inhalation Sciences Sweden AB, Pharmaceuticals & Healthcare, Key Facts 2

Inhalation Sciences Sweden AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Inhalation Sciences Sweden AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Inhalation Sciences Sweden AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Inhalation Sciences Sweden AB, Deals By Therapy Area, 2012 to YTD 2018 8

Inhalation Sciences Sweden AB, Medical Devices Deals, 2012 to YTD 2018 9

Inhalation Sciences Sweden AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Inhalation Sciences Raises Funds through Venture Financing 11

Inhalation Sciences Raises USD0.4 million in Private Placement of Shares 12

KDev Investments Sells Stake in Inhalation Sciences 13

BrainsToVentures And Rosetta Capital Acquire Minority Stake In 13 Portfolio Companies Of Karolinska Development For USD 34 Million 14

Inhalation Sciences Sweden AB, Key Competitors 17

Inhalation Sciences Sweden AB, Key Employees 18

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Inhalation Sciences Sweden AB, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Inhalation Sciences Sweden AB (ISAB) develops and sells innovative laboratory equipment for inhalation research and provides drug development services. The company's product portfolio includes PreciseInhale and LaminarPace systems. It sells tools and services which accelerates the drug discovery timelines to reduce attrition rates in the clinical phase. ISAB's PreciseInhale, is an advanced laboratory technology system for inhalation drug development in therapeutic areas of asthma and COPD (chronic obstructive pulmonary disease), migraine, impotence, diabetes and influenza. Its PreciseInhale platform is used for screening and preclinical evaluation of candidate drugs and new drug formulations intended for inhalation. The company offers data for pharmacokinetic studies to labs, pharma and research companies. ISAB is headquartered in Huddinge, Sweden.

Inhalation Sciences Sweden AB-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Inhalation Sciences Sweden AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Inhalation Sciences Sweden AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Inhalation Sciences Sweden AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Inhalation Sciences Sweden AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Inhalation Sciences Sweden AB, Medical Devices Deals, 2012 to YTD 2018 9

Inhalation Sciences Sweden AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Inhalation Sciences Sweden AB, Pharmaceuticals & Healthcare, Deal Details 11

Venture Financing 11

Inhalation Sciences Raises Funds through Venture Financing 11

Equity Offering 12

Inhalation Sciences Raises USD0.4 million in Private Placement of Shares 12

Acquisition 13

KDev Investments Sells Stake in Inhalation Sciences 13

BrainsToVentures And Rosetta Capital Acquire Minority Stake In 13 Portfolio Companies Of Karolinska Development For USD 34 Million 14

Inhalation Sciences Sweden AB-Key Competitors 17

Inhalation Sciences Sweden AB-Key Employees 18

Inhalation Sciences Sweden AB-Locations And Subsidiaries 19

Head Office 19

Recent Developments 20

Financial Announcements 20

Aug 22, 2018: Inhalation Sciences publishes interim report for the second quarter of 2018 20

Corporate Communications 22

Apr 19, 2018: Inhalation Sciences Names Lena Heffler As CEO 22

Government and Public Interest 23

Oct 26, 2017: AstraZeneca report finds PreciseInhale 'reduces the risk' of failure when developing inhaled drugs 23

Other Significant Developments 24

May 08, 2018: Inhalation Sciences' new CEO Lena Heffler: science, sales, win-win 24

Appendix 25

Methodology 25

About GlobalData 25

Contact Us 25

Disclaimer 25


List Of Figure

List of Figures

Inhalation Sciences Sweden AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Inhalation Sciences Sweden AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Inhalation Sciences Sweden AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Inhalation Sciences Sweden AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Inhalation Sciences Sweden AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Inhalation Sciences Sweden AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Inhalation Sciences Sweden AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Inhalation Sciences Sweden AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Inhalation Sciences Sweden AB, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Inhalation Sciences Sweden AB, Pharmaceuticals & Healthcare, Key Facts 2

Inhalation Sciences Sweden AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Inhalation Sciences Sweden AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Inhalation Sciences Sweden AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Inhalation Sciences Sweden AB, Deals By Therapy Area, 2012 to YTD 2018 8

Inhalation Sciences Sweden AB, Medical Devices Deals, 2012 to YTD 2018 9

Inhalation Sciences Sweden AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Inhalation Sciences Raises Funds through Venture Financing 11

Inhalation Sciences Raises USD0.4 million in Private Placement of Shares 12

KDev Investments Sells Stake in Inhalation Sciences 13

BrainsToVentures And Rosetta Capital Acquire Minority Stake In 13 Portfolio Companies Of Karolinska Development For USD 34 Million 14

Inhalation Sciences Sweden AB, Key Competitors 17

Inhalation Sciences Sweden AB, Key Employees 18

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Inhalation Sciences Sweden AB, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.